SB-505124
SB-505124 is a selective inhibitor of TGF-β Receptor type I receptors (ALK4, ALK5, ALK7), with IC50s of 129 nM and 47 nM for ALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.
Product Specifications
CAS Number
694433-59-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
TGF-β Receptor
Type
Reference compound
Related Pathways
TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sb-505124.html
Concentration
10mM
Purity
99.73
Solubility
DMSO : 113.33 mg/mL (ultrasonic)
Smiles
CC1=CC=CC(C2=C(C3=CC=C(OCO4)C4=C3)N=C(C(C)(C)C)N2)=N1
Molecular Formula
C20H21N3O2
Molecular Weight
335.40
Precautions
H302, H315, H319, H335
References & Citations
[1]DaCosta Byfield S, et al. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2004 Mar;65 (3) :744-52.|[2]Sutariya V, et al. Thermoreversible gel for delivery of receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery. Pharm Dev Technol. 2013 Jul-Aug;18 (4) :957-62.|[3]Sapitro J, et al. Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by receptor-like kinase 5 inhibitor. Mol Vis. 2010 Sep 16;16:1880-92.|[4]Marini KD, et al. Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy. Sci Transl Med. 2018 Jul 25;10 (451) . pii: eaat3504.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042231-100 1x 100 µL
14-3-3E / Tryptophan 5-Monooxygenase (CPTC-YWHAE-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941071-100 1x 100 µL
Ksp-Cadherin / CDH16 (CDH16/1071), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 